Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin in 1st-line Metastatic Esophageal Squamous Cell Carcinoma
NCT03002064Phase 3Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Dec 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
docetaxel
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT03002064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03002064.